Related Experiment Videos
Building on the past--challenging the future: will genomics provide the solution to hypertension?
1Department of Nephrology and Hypertension, Ben-Gurion University Barzilai Medical Center Campus, Israel. labmomed@bgumail.bgu.ac.il
Insights
Genomics offers potential solutions for understanding hypertension, a complex polygenic disease causing significant global mortality. Further research is needed to fully harness genomic insights for improved hypertension treatment and prevention.
Area of Science:
- Genetics and Genomics
- Cardiovascular Disease Research
- Public Health
Background:
- Hypertension is a prevalent, multifactorial disease with significant global morbidity and mortality.
- The underlying pathophysiological mechanisms of hypertension remain largely unknown, hindering effective treatment and prevention strategies.
- Genomics is increasingly explored for its potential to unravel complex diseases like hypertension.
Purpose of the Study:
- To explore the role of genomics in understanding the causes of hypertension.
- To assess the potential of genomics to improve the classification of hypertensive syndromes.
- To investigate how genomic insights can enhance personalized anti-hypertensive therapy and outcome prediction.
Main Methods:
- This abstract discusses the potential applications of genomics in hypertension research.
- It highlights the need for well-defined research questions to guide genomic studies.
- The abstract emphasizes the importance of perseverance in genomic research.
Main Results:
- Genomics holds promise for advancing our understanding of hypertension's pathophysiology.
- Genomic approaches may lead to more precise classification of hypertensive syndromes.
- Genomic data could enable tailored anti-hypertensive treatments and improved outcome prediction.
Conclusions:
- Genomics offers significant potential to address critical unanswered questions in hypertension.
- Further research and a strong belief in genomic capabilities are essential for progress.
- Harnessing the human genome's potential is key to improving hypertension management.
Abstract:
Hypertension is one of the major common polygenic and multifactorial diseases, and continues to constitute a major cause of morbidity and mortality worldwide. The pathophysiological mechanisms underlying hypertension have not been elucidated, which significantly limits our ability to treat and prevent hypertension. A frequently asked question is whether genomics will provide the solution to the many remaining unanswered questions as to the causes of hypertension. Genomics, an art by its own virtue, holds its promises, yet the questions we are asking of genomics must be well defined for genomics to meet at least some of our expectations. The hopes and promises of genomics are high and one of the major hopes is that genomics will improve our understanding of the pathophysiology of hypertension and enable us to classify hypertensive syndromes more succinctly and enhance our ability to provide patients with specific anti-hypertensive therapy as well as predict outcome. There is still much to be done but perseverance in the task and a firm belief in genomics and in the immense potential of the human genome is essential.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetics and Pharmacogenomics: Overview
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Genomics
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
What is Genetic Engineering?